1887

Abstract

Summary

We studied the immunoglobulin response to individual viral polypeptides in experimental primary and secondary infection with herpes simplex virus (HSV)-1 in mice. After a single footpad inoculation with 10 pfu of HSV-1, immunoglobulin to proteins mol. wts (10) 44 and 75 appeared on day 7. Antibodies to gB, gC, gD, 42 × 10- and (48–52) × 10-mol. wt proteins appeared on day 11 and antibody to the major capsid protein, VP154, appeared on day 15 after infection. The secondary immune response was characterised by early production of antibody to gD on day 3 followed by antibodies against the 42 × 10- and 44 × 10-mol. wt proteins on days 4 and 5 respectively. Antibodies to glycoprotein gC and gB were delayed until day 7 of the secondary immune response. In both primary and secondary immune responses the responses against proteins of mol. wts (10) 42 and 44 were particularly intense and of high titre. We conclude that the kinetics of anti-polypeptide antibody appearance is markedly asynchronous; and that the anti-glycoprotein responses occur too late in primary infection to contribute to viral clearance.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-25-1-59
1988-01-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/25/1/medmicro-25-1-59.html?itemId=/content/journal/jmm/10.1099/00222615-25-1-59&mimeType=html&fmt=ahah

References

  1. Balachandran N, Bacchetti S, Rawls W E. 1982; Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Infection and Immunity 37:1132–1137
    [Google Scholar]
  2. Berman P W, Gregory T, Crase D, Lasky L A. 1985; Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D. Science 227:1490–1492
    [Google Scholar]
  3. Bernstein D I, Lovett M A, Bryson Y J. 1984; The effects of acyclovir on antibody response to herpes simplex virus in primary genital herpetic infections. Journal of Infectious Diseases 150:7–13
    [Google Scholar]
  4. Dix R D, Mills J. 1985; Acute and latent herpes simplex virus neurological disease in mice immunised with purified virus-specific glycoprotein gB or glycoprotein gD. Journal of Medical Virology 17:9–18
    [Google Scholar]
  5. Dix R D, Pereira L, Baringer J R. 1981; Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Infection and Immunity 34:192–199
    [Google Scholar]
  6. Eberle R, Mou S-W. 1983; Relative titers of antibodies to individual polypeptide antigens of herpes simplex virus type 1 in human sera. Journal of Infectious Diseases 148:436–444
    [Google Scholar]
  7. Eberle R, Mou S-W, Zaia J A. 1984; Polypeptide specificity of the early antibody response following primary and recurrent genital herpes simplex virus type 2 infections. Journal of General Virology 65:1839–1843
    [Google Scholar]
  8. Eberle R, Mou S-W, Zaia J A. 1985; The immune response to herpes simplex virus: Comparison of the specificity and relative titers of serum antibodies directed against viral polypeptides following herpes simplex virus type 1 infections. Journal of Medical Virology 16:147–162
    [Google Scholar]
  9. Eisenberg R J. 1985; Synthetic glycoprotein d-related peptides protect mice against herpes simplex virus challenge. Journal of Virology 56:1014–1017
    [Google Scholar]
  10. Heilman C J, Zweig M, Hampar B. 1981; Herpes simplex virus type 1 and 2 intracellular p40: type-specific and cross-reactive antigenic determinants on peptides generated by partial proteolysis. Journal of Virology 40:508–515
    [Google Scholar]
  11. Kahlon J, Lakeman F D, Ackermann M, Whitley R J. 1986; Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection. Journal of Clinical Microbiology 23:725–730
    [Google Scholar]
  12. Knotts F B, Cook M L, Stevens J G. 1974; Pathogenesis of herpetic-encephalitis in mice after ophthalmic inoculation. Journal of Infectious Diseases 130:16–27
    [Google Scholar]
  13. Kümel G, Kaerner H C, Levine M, Schroder C H, Glorioso J C. 1985; Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity. Journal of Virology 56:930–937
    [Google Scholar]
  14. Laemmli U K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
    [Google Scholar]
  15. Mann D R, Hilty M D. 1982; Antibody response to herpes simplex virus type 1 polypeptides and glycoproteins in primary and recurrent infection. Pediatric Research 16:176–180
    [Google Scholar]
  16. McKendall R R. 1985; IgG-mediated viral clearance in experimental infection with herpes simplex virus type 1: Role for neutralization and Fc-dependent functions but not C Cytolysis and C5 Chemotaxis. Journal of Infectious Diseases 151:464–470
    [Google Scholar]
  17. McKendall R R, Baringer J R. 1981; Evidence for B-cell effectiveness on peripheral challenge by HSV-1 in mice. Nahmias A. J. The Human Herpesviruses: an interdisciplinary perspective Elsevier/North Holland Publishers; New York:647
    [Google Scholar]
  18. McKendall R R, Pettit M, Woo W. 1987; The immunoglobulin response to HSV-1 viral proteins: Determination of immunogenic proteins and relative antibody titers to individual polypeptides by immunoblotting. Journal of Medical Microbiology 24:49–57
    [Google Scholar]
  19. Morahan P S, Breinig M C, McGeorge M B. 1977; Immune responses to vaginal or systemic infection of BALB/c mice with herpes simplex virus type 2. Journal of Immunology 119:2030–2036
    [Google Scholar]
  20. Morahan P S, Thomson T A, Kohl S, Murray B K. 1981; Immune responses to labial infection of BALB/c mice with herpes simplex virus type 1. Infection and Immunity 32:180–187
    [Google Scholar]
  21. Oakes J E. 1975; Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection. Infection and Immunity 12:166–172
    [Google Scholar]
  22. Preston V G, Coates J A V, Rixon F J. 1983; Identification and characterization of a herpes simplex virus gene product required for encapsidation of virus DNA. Journal of Virology 45:1056–1064
    [Google Scholar]
  23. Rager-Zisman B, Allison A C. 1976; Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection. Journal of Immunology 116:35–40
    [Google Scholar]
  24. Rector J T, Lausch R N, Oakes J E. 1982; Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection. Infection and Immunity 38:168–174
    [Google Scholar]
  25. Rosenberg G L, Notkins A L. 1974; Induction of cellular immunity to herpes simplex virus: Relationship to the humoral immune response. Journal of Immunology 112:1019–1025
    [Google Scholar]
  26. Towbin H, Staehelin T, Gordon J. 1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proceedings of the National Academy of Sciences of the USA 76:4350–4354
    [Google Scholar]
  27. Zaia J A, Palmer E L, Feorino P M. 1975; Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus. Journal of Infectious Diseases 132:660–666
    [Google Scholar]
  28. Zweig M, Heilman C J, Rabin H, Hampar B. 1980; Shared antigenic determinants between two distinct classes of proteins in cells infected with herpes simplex virus. Journal of Virology 35:644–652
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-25-1-59
Loading
/content/journal/jmm/10.1099/00222615-25-1-59
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error